Nucleoside inhibitors of tick-borne encephalitis virus. 2015

Luděk Eyer, and James J Valdés, and Victor A Gil, and Radim Nencka, and Hubert Hřebabecký, and Michal Šála, and Jiří Salát, and Jiří Černý, and Martin Palus, and Erik De Clercq, and Daniel Růžek
Department of Virology, Veterinary Research Institute, Brno, Czech Republic.

Tick-borne encephalitis virus (TBEV) is a leading cause of human neuroinfections in Europe and Northeast Asia. There are no antiviral therapies for treating TBEV infection. A series of nucleoside analogues was tested for the ability to inhibit the replication of TBEV in porcine kidney cells and human neuroblastoma cells. The interactions of three nucleoside analogues with viral polymerase were simulated using advanced computational methods. The nucleoside analogues 7-deaza-2'-C-methyladenosine (7-deaza-2'-CMA), 2'-C-methyladenosine (2'-CMA), and 2'-C-methylcytidine (2'-CMC) inhibited TBEV replication. These compounds showed dose-dependent inhibition of TBEV-induced cytopathic effects, TBEV replication (50% effective concentrations [EC50]of 5.1 ± 0.4 μM for 7-deaza-2'-CMA, 7.1 ± 1.2 μM for 2'-CMA, and 14.2 ± 1.9 μM for 2'-CMC) and viral antigen production. Notably, 2'-CMC was relatively cytotoxic to porcine kidney cells (50% cytotoxic concentration [CC50] of ∼50 μM). The anti-TBEV effect of 2'-CMA in cell culture diminished gradually after day 3 posttreatment. 7-Deaza-2'-CMA showed no detectable cellular toxicity (CC50 > 50 μM), and the antiviral effect in culture was stable for >6 days posttreatment. Computational molecular analyses revealed that compared to the other two compounds, 7-deaza-2'-CMA formed a large cluster near the active site of the TBEV polymerase. High antiviral activity and low cytotoxicity suggest that 7-deaza-2'-CMA is a promising candidate for further investigation as a potential therapeutic agent in treating TBEV infection.

UI MeSH Term Description Entries
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003562 Cytidine A pyrimidine nucleoside that is composed of the base CYTOSINE linked to the five-carbon sugar D-RIBOSE. Cytosine Ribonucleoside,Cytosine Riboside,Ribonucleoside, Cytosine,Riboside, Cytosine
D004669 Encephalitis Viruses, Tick-Borne A subgroup of the genus FLAVIVIRUS that causes encephalitis and hemorrhagic fevers and is found in eastern and western Europe and the former Soviet Union. It is transmitted by TICKS and there is an associated milk-borne transmission from viremic cattle, goats, and sheep. Hemorrhagic Fever Virus, Omsk,Kyasanur Forest disease virus,Langat virus,Louping ill virus,Omsk hemorrhagic fever virus,Powassan virus,Al-Khurma Hemorrhagic Fever Virus,Al-Khurma virus,Al-Khurma virus (ALKV),Alkhurma Hemorrhagic Fever Virus,Alkhurma virus,Alkhurma virus (ALKV),Encephalitis Virus, Tick-Borne,Tick-Borne Encephalitis Virus,Tick-Borne Encephalitis Viruses,Viruses, Tick-Borne Encephalitis,Al Khurma Hemorrhagic Fever Virus,Al Khurma virus,Al Khurma virus (ALKV),Encephalitis Virus, Tick Borne,Encephalitis Viruses, Tick Borne,Louping ill viruses,Tick Borne Encephalitis Virus,Tick Borne Encephalitis Viruses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog
D014372 Tubercidin An antibiotic purine ribonucleoside that readily substitutes for adenosine in the biological system, but its incorporation into DNA and RNA has an inhibitory effect on the metabolism of these nucleic acids. 7-Deazaadenosine,4-Amino-7 beta-D-ribofuranosyl-7H-pyrrolo(2,3-d)pyrimidine,Deazaadenosine,7 Deazaadenosine

Related Publications

Luděk Eyer, and James J Valdés, and Victor A Gil, and Radim Nencka, and Hubert Hřebabecký, and Michal Šála, and Jiří Salát, and Jiří Černý, and Martin Palus, and Erik De Clercq, and Daniel Růžek
March 2017, Bioorganic & medicinal chemistry letters,
Luděk Eyer, and James J Valdés, and Victor A Gil, and Radim Nencka, and Hubert Hřebabecký, and Michal Šála, and Jiří Salát, and Jiří Černý, and Martin Palus, and Erik De Clercq, and Daniel Růžek
May 2022, Journal of medical microbiology,
Luděk Eyer, and James J Valdés, and Victor A Gil, and Radim Nencka, and Hubert Hřebabecký, and Michal Šála, and Jiří Salát, and Jiří Černý, and Martin Palus, and Erik De Clercq, and Daniel Růžek
May 2011, Emerging infectious diseases,
Luděk Eyer, and James J Valdés, and Victor A Gil, and Radim Nencka, and Hubert Hřebabecký, and Michal Šála, and Jiří Salát, and Jiří Černý, and Martin Palus, and Erik De Clercq, and Daniel Růžek
September 2016, Antiviral research,
Luděk Eyer, and James J Valdés, and Victor A Gil, and Radim Nencka, and Hubert Hřebabecký, and Michal Šála, and Jiří Salát, and Jiří Černý, and Martin Palus, and Erik De Clercq, and Daniel Růžek
April 1997, Acta virologica,
Luděk Eyer, and James J Valdés, and Victor A Gil, and Radim Nencka, and Hubert Hřebabecký, and Michal Šála, and Jiří Salát, and Jiří Černý, and Martin Palus, and Erik De Clercq, and Daniel Růžek
January 1967, Acta virologica,
Luděk Eyer, and James J Valdés, and Victor A Gil, and Radim Nencka, and Hubert Hřebabecký, and Michal Šála, and Jiří Salát, and Jiří Černý, and Martin Palus, and Erik De Clercq, and Daniel Růžek
December 2001, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Luděk Eyer, and James J Valdés, and Victor A Gil, and Radim Nencka, and Hubert Hřebabecký, and Michal Šála, and Jiří Salát, and Jiří Černý, and Martin Palus, and Erik De Clercq, and Daniel Růžek
January 2020, Emerging infectious diseases,
Luděk Eyer, and James J Valdés, and Victor A Gil, and Radim Nencka, and Hubert Hřebabecký, and Michal Šála, and Jiří Salát, and Jiří Černý, and Martin Palus, and Erik De Clercq, and Daniel Růžek
November 1965, Acta virologica,
Luděk Eyer, and James J Valdés, and Victor A Gil, and Radim Nencka, and Hubert Hřebabecký, and Michal Šála, and Jiří Salát, and Jiří Černý, and Martin Palus, and Erik De Clercq, and Daniel Růžek
May 2020, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!